Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Test number's
View:
Post by frewil11 on Aug 21, 2022 1:01pm

Test number's

I can not see any reason why they can't give out how many Aristotle tests they have performed since the launch, they don't have to say from who or where they came from , they know the exact number .
Comment by 4real4ever on Aug 21, 2022 1:20pm
I give you one reason my old pumper the number is 0
Comment by Liked2Think on Aug 22, 2022 10:45am
Lets see 1. Tripp said CARE did $4M in revenue a year before Stage bought them.  This was 16 months ago. 2. 16 months ago they "launched" aristotle 3. Last quarterly results were $1M in revenue. You have two ways to look at this. 1. Tripp lied and CARE was not making that much and they are doing aristotle testing 2. They have sold little to no aristotle tests Which one is the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities